KRAS Variants

ESMO Open Shared 2025 Study Linking KRAS Variants to Therapeutic Outcomes in Biliary Tract Cancers

ESMO Open shared a post on X:

“Association of KRAS variants with survival and therapeutic outcomes in biliary tract cancers in ESMO Open.
KRAS mutations occur in 23.4% of BTC, more frequent in intrahepatic and extrahepatic colangiocarcinoma, and associated with worse survival.”

Title: Association of KRAS variants with survival and therapeutic outcomes in biliary tract cancers

Journal: ESMO Open

Authors: K. Iida, Y. Matsui, Y. Urabe, T. Muramatsu, J. Matsuzaki, Y. Saito

Read the full article.

KRAS Variants

More posts featuring ESMO Open on OncoDaily.